Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 USD | -3.77% | +18.15% | +21.06% |
05-07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
05-07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.06% | 407M | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+5.88% | 6.59B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
-29.53% | 2.66B | |
+47.29% | 2.37B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Morgan Stanley Adjusts Price Target on Bioventus to $5 From $11, Maintains Overweight Rating